Filana Therapeutics (FLNA) EV to EBIT (2010 - 2026)
Filana Therapeutics (FLNA) posted EV to EBIT of 2.68 for Q2 2026, up 507.29% on a QoQ basis from 0.44 in Q1 2026, and up 388.11% year-over-year from 0.55 in Q2 2025.
Analysis
Filana Therapeutics (FLNA) EV to EBIT (2010 - 2026) Analysis & Trends
Filana Therapeutics has reported EV to EBIT for 17 years, with the latest figure at 2.68 in Q2 2026.
- On a quarterly basis, EV to EBIT rose 388.11% year-over-year to 2.68 in Q2 2026; TTM through Jun 2026 was 0.55, a 185.81% increase from a year earlier, with the FY2025 full-year figure at 0.0, down 101.48% from the prior year.
- EV to EBIT was 2.68 for Q2 2026 at Filana Therapeutics, up from 0.44 in the prior quarter.
- The five-year high for EV to EBIT was 2.68 in Q2 2026, with the low at 71.66 in Q1 2022.
- Average EV to EBIT over 5 years is 24.23, with a median of 24.95 recorded in 2023.
- The sharpest annual moves came in 2025 and 2026: EV to EBIT slumped 102.17% in 2025, then soared 388.11% in 2026.
- Over 5 years, EV to EBIT stood at 49.28 in 2022, then grew by 26.13% to 36.4 in 2023, then jumped by 101.38% to 0.5 in 2024, then plunged by 102.17% to 0.01 in 2025, then jumped by 24721.65% to 2.68 in 2026.
- The last three EV to EBIT figures came in at 2.68 (Q2 2026), 0.44 (Q1 2026), and 0.01 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Filana Therapeutics | 38.14 Mn | 38.14 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.68 |
| Mar 31, 2026 | 0.44 |
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | -2.91 |
| Jun 30, 2025 | 0.55 |
| Mar 31, 2025 | 1.82 |
| Dec 31, 2024 | 0.50 |
| Sep 30, 2024 | -39.94 |
| Jun 30, 2024 | -6.27 |
| Mar 31, 2024 | -37.79 |
| Dec 31, 2023 | -36.40 |
| Sep 30, 2023 | -20.04 |
| Jun 30, 2023 | -29.87 |
| Mar 31, 2023 | -30.91 |
| Dec 31, 2022 | -49.28 |
| Sep 30, 2022 | -70.30 |
| Jun 30, 2022 | -46.71 |
| Mar 31, 2022 | -71.66 |
| Dec 31, 2021 | -104.91 |
| Sep 30, 2021 | -229.95 |